Overview

Keytruda is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of bladder cancer. It is prescribed to treat advanced or metastatic (spreading) urothelial cancer, nonmuscle invasive…

Overview
Opdivo is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of bladder cancer, called urothelial carcinoma. It can be used after surgery to lower the risk of the cancer coming back in…

Overview
Padcev is approved by the U.S. Food and Drug Administration (FDA) to treat several forms of bladder cancer. It is approved in combination with pembrolizumab (Keytruda) or with pembrolizumab and berahyaluronidase…

Overview
Tice BCG is approved by the U.S. Food and Drug Administration (FDA) to treat and prevent carcinoma in situ (CIS, a type of bladder cancer that stays on the bladder lining). It is also used to prevent the…